Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 688
Filter
Add more filters

Publication year range
1.
Gynecol Endocrinol ; 38(2): 170-175, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34964405

ABSTRACT

AIMS: Ginkgo biloba extract (EGb) has been widely applied in the treatment of cerebrovascular and neurological diseases. However, the effect of EGb761 on ovarian hyperstimulation syndrome (OHSS), a vascular disorder and life-threatening complication of In Vitro Fertilization and Intracytoplasmic Sperm Injection therapy (IVF/ICSI), has not been evaluated. MATERIALS AND METHODS: Forty female Wistar rats aged 22-days old (D22) were divided into eight groups: Control rats received intraperitoneal injection of saline for 5 consecutive days (D22-D26); OHSS model group received 10 IU equine chorionic gonadotropin (eCG) for 4 consecutive days (D22-D25) and 30 IU of human chorionic gonadotropin (hCG) on the 5th day (D26); Prophylactic treatment group received three doses of EGb761 (50, 100, and 200 mg/kg/d) one hour before injection of eCG (hCG) for 7 consecutive days; Therapeutic treatment group received three doses of EGb761 (50, 100, and 200 mg/kg/d) 48 h after injection of eCG (hCG) for 7 consecutive days. RESULTS: All three doses of EGb761 therapeutic medication significantly reduced ovarian mass index in the OHSS model (p ≤ .01). Further, the therapeutic treatment group exhibited improved vascular permeability, decreased estradiol and progesterone levels, lower corpus luteum, and higher follicle numbers compared with the OHSS model. Elevated protein expression of vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) in both ovary and kidney of the OHSS model was restrained by EGb761 therapeutic treatment. CONCLUSIONS: EGb761 therapeutic medication decreases vascular permeability in OHSS rat model by inhibiting VEGF and VEGFR expression, which may contribute to the treatment of OHSS.


Subject(s)
Ovarian Hyperstimulation Syndrome , Plant Extracts , Animals , Capillary Permeability/drug effects , Chorionic Gonadotropin/pharmacology , Female , Ginkgo biloba/chemistry , Horses , Humans , Ovarian Hyperstimulation Syndrome/drug therapy , Ovarian Hyperstimulation Syndrome/prevention & control , Plant Extracts/pharmacology , Rats , Rats, Wistar , Vascular Endothelial Growth Factor A/metabolism
2.
Pak J Pharm Sci ; 34(3): 943-949, 2021 May.
Article in English | MEDLINE | ID: mdl-34602417

ABSTRACT

Allium sativum (As), commonly known as garlic, has been used for a long time, for its therapeutic effects. Recent studies showed the ability of As to modulate vascular activity. The present study aimed to investigate the vasomodulatory effects of aqueous extract of As and to analyse the molecular nature of the active components. Experiments were performed on chick chorioallantoic membrane. Fractions of garlic were directly injected using micropipette on a high vessel density area. Our results clearly indicated that garlic increased permeability and induced vasodilatation of blood vessels and capillaries. These effects were dose-dependent and had been observed just few minutes after the onset of treatment. The active component responsible of these effects, which had a low molecular weight seems to be of peptide nature and appeared different from Dially Sulfide (DAS) and Dially Disulfide (DADS).


Subject(s)
Blood Vessels/drug effects , Capillary Permeability/drug effects , Chorioallantoic Membrane/drug effects , Garlic , Plant Extracts/pharmacology , Vasodilation/drug effects , Animals , Chick Embryo , Chorioallantoic Membrane/blood supply , Chromatography, Thin Layer , Dose-Response Relationship, Drug , Plant Extracts/chemistry
3.
Molecules ; 26(16)2021 Aug 10.
Article in English | MEDLINE | ID: mdl-34443414

ABSTRACT

Natural antioxidants, especially those of plant origins, have shown a plethora of biological activities with substantial economic value, as they can be extracted from agro-wastes and/or under exploited plant species. The perennial hydrophyte, Potamogeton perfoliatus, has been used traditionally to treat several health disorders; however, little is known about its biological and its medicinal effects. Here, we used an integrated in vitro and in vivo framework to examine the potential effect of P. perfoliatus on oxidative stress, nociception, inflammatory models, and brewer's yeast-induced pyrexia in mice. Our results suggested a consistent in vitro inhibition of three enzymes, namely 5-lipoxygenase, cyclooxygenases 1 and 2 (COX-1 and COX-2), as well as a potent antioxidant effect. These results were confirmed in vivo where the studied extract attenuated carrageenan-induced paw edema, carrageenan-induced leukocyte migration into the peritoneal cavity by 25, 44 and 64% at 200, 400 and 600 mg/kg, p.o., respectively. Moreover, the extract decreased acetic acid-induced vascular permeability by 45% at 600 mg/kg, p.o., and chemical hyperalgesia in mice by 86% by 400 mg/kg, p.o., in acetic acid-induced writhing assay. The extract (400 mg/kg) showed a longer response latency at the 3 h time point (2.5 fold of the control) similar to the nalbuphine, the standard opioid analgesic. Additionally, pronounced antipyretic effects were observed at 600 mg/kg, comparable to paracetamol. Using LC-MS/MS, we identified 15 secondary metabolites that most likely contributed to the obtained biological activities. Altogether, our findings indicate that P. perfoliatus has anti-inflammatory, antioxidant, analgesic and antipyretic effects, thus supporting its traditional use and promoting its valorization as a potential candidate in treating oxidative stress-associated diseases.


Subject(s)
Analgesics/pharmacology , Anti-Inflammatory Agents/pharmacology , Antipyretics/pharmacology , Plant Extracts/pharmacology , Potamogetonaceae/chemistry , Acetic Acid , Animals , Antioxidants/pharmacology , Behavior, Animal/drug effects , Capillary Permeability/drug effects , Carrageenan , Cell Movement/drug effects , Chromatography, High Pressure Liquid , Drug Evaluation, Preclinical , Edema/pathology , Fever/pathology , Iridoid Glucosides/pharmacology , Leukocytes/drug effects , Male , Mice , Peritoneal Cavity/pathology , Phenylpropionates/pharmacology , Phytochemicals/analysis , Rats , Saccharomyces cerevisiae
4.
Int J Mol Sci ; 22(9)2021 May 04.
Article in English | MEDLINE | ID: mdl-34064508

ABSTRACT

During tumor growth, angiogenesis is required to ensure oxygen and nutrient transport to the tumor. Vascular endothelial growth factor (VEGF) is the major inducer of angiogenesis and appears to be a key modulator of the anti-tumor immune response. Indeed, VEGF modulates innate and adaptive immune responses through direct interactions and indirectly by modulating protein expressions on endothelial cells or vascular permeability. The inhibition of the VEGF signaling pathway is clinically approved for the treatment of several cancers. Therapies targeting VEGF can modulate the tumor vasculature and the immune response. In this review, we discuss the roles of VEGF in the anti-tumor immune response. In addition, we summarize therapeutic strategies based on its inhibition, and their clinical approval.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Immunologic Factors/therapeutic use , Neoplasms/drug therapy , Neovascularization, Pathologic/prevention & control , Vascular Endothelial Growth Factor A/genetics , Vascular Endothelial Growth Factor Receptor-1/antagonists & inhibitors , Adaptive Immunity/drug effects , Antibodies, Monoclonal, Humanized/therapeutic use , Bevacizumab/therapeutic use , Capillary Permeability/drug effects , Endothelial Cells/drug effects , Endothelial Cells/immunology , Endothelial Cells/pathology , Gene Expression Regulation, Neoplastic , Humans , Immunity, Innate/drug effects , Neoplasms/genetics , Neoplasms/immunology , Neoplasms/pathology , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/immunology , Neovascularization, Pathologic/pathology , Receptors, Vascular Endothelial Growth Factor/therapeutic use , Recombinant Fusion Proteins/therapeutic use , Signal Transduction , Sorafenib/therapeutic use , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/immunology , Vascular Endothelial Growth Factor Receptor-1/genetics , Vascular Endothelial Growth Factor Receptor-1/immunology , Ramucirumab
5.
Fluids Barriers CNS ; 18(1): 28, 2021 Jun 22.
Article in English | MEDLINE | ID: mdl-34158083

ABSTRACT

BACKGROUND: The blood-brain barrier (BBB) plays a critical role in protecting the central nervous system (CNS) from blood-borne agents and potentially harmful xenobiotics. Our group's previous data has shown that tobacco smoke (TS) and electronic cigarettes (EC) affect the BBB integrity, increase stroke incidence, and are considered a risk factor for multiple CNS disorders. Metformin was also found to abrogate the adverse effects of TS and EC. METHODS: We used sucrose and mannitol as paracellular markers to quantitatively assess TS and EC's impact on the BBB in-vitro. Specifically, we used a quantitative platform to determine the harmful effects of smoking on the BBB and study the protective effect of metformin. Using a transwell system and iPSCs-derived BMECs, we assessed TS and EC's effect on sucrose and mannitol permeability with and without metformin pre-treatment at different time points. Concurrently, using immunofluorescence (IF) and Western blot (WB) techniques, we evaluated the expression and distribution of tight junction proteins, including ZO-1, occludin, and claudin-5. RESULTS: Our data showed that TS and EC negatively affect sucrose and mannitol permeability starting after 6 h and up to 24 h. The loss of barrier integrity was associated with a reduction of TEER values. While the overall expression level of ZO-1 and occludin was not significantly downregulated, the distribution of ZO-1 was altered, and discontinuation patterns were evident through IF imaging. In contrast to occludin, claudin-5 expression was significantly decreased by TS and EC, as demonstrated by WB and IF data. CONCLUSION: In agreement with previous studies, our data showed the metformin could counteract the negative impact of TS and EC on BBB integrity, thus suggesting the possibility of repurposing this drug to afford cerebrovascular protection.


Subject(s)
Blood-Brain Barrier/metabolism , E-Cigarette Vapor/adverse effects , Metformin/administration & dosage , Neuroprotection/drug effects , Smoke/adverse effects , Tight Junctions/metabolism , Tobacco Products , Blood-Brain Barrier/drug effects , Capillary Permeability/drug effects , Capillary Permeability/physiology , Cell Survival/drug effects , Cell Survival/physiology , Claudin-5/metabolism , Drug Evaluation, Preclinical/methods , E-Cigarette Vapor/administration & dosage , Humans , Induced Pluripotent Stem Cells/drug effects , Induced Pluripotent Stem Cells/metabolism , Neuroprotection/physiology , Occludin/metabolism , Tight Junctions/drug effects , Zonula Occludens-1 Protein/metabolism
6.
Mol Immunol ; 135: 408-420, 2021 07.
Article in English | MEDLINE | ID: mdl-33518365

ABSTRACT

Jing-Fang powder (Schizonepeta tenuifolia Briq. and Saposhnikovia divaricata (Turcz.) Schischk.) was used to treat chronic bronchitis, asthma and chronic urticaria. Based on the preliminary results of screening research on the antiallergic effective parts of Jing-Fang powder, its ethyl acetate extract fractions (JFEE) and isolate D (JFEE-D) showed the best anti-allergic effect. RBL-2H3 cell activation degranulation model and mice passive cutaneous anaphylaxis (PCA) reaction model were used to investigate the effects and mechanisms of JFEE and JFEE-D on IgE-mediated type I allergic reactions. LC-MS was utilized to determine the composition of JFEE and JFEE-D. We found that JFEE and JFEE-D significantly reduced ß-HEX, histamine, IL-4, IL-6 levels in cell supernatants, and improved the degree and morphology of cell degranulation. JFEE and JFEE-D significantly inhibited the increase of ear vascular permeability and abnormal increase of serum IgE, TNF-α, IL-6 levels. JFEE and JFEE-D inhibited mRNA expression of PI3K and Akt and down-regulated protein expression of PI3K, Akt, p-Akt, and PLCγ1 in sensitized RBL-2H3 cells. The combined use of JFEE and JFEE-D with pathway inhibitor Wortmannin revealed synergistic down-regulation of PI3K, Akt, and p-Akt protein expression. The combined use of pathway agonist IGF-1, JFEE and JFEE-D down-regulated increase of p-Akt/Akt protein expression. Moreover, JFEE and JFEE-D significantly inhibited protein expression of PI3K, p-Akt and PLCγ1 in PCA model mice. These results show that JFEE and JFEE-D inhibit type I allergic reactions by inhibiting PI3K/Akt signaling pathway.


Subject(s)
Anti-Allergic Agents/pharmacology , Apiaceae/chemistry , Lamiaceae/chemistry , Phosphatidylinositol 3-Kinases/metabolism , Plant Extracts/pharmacology , Proto-Oncogene Proteins c-akt/metabolism , Anaphylaxis/drug therapy , Anaphylaxis/prevention & control , Animals , Asthma/drug therapy , Bronchitis, Chronic/drug therapy , Capillary Permeability/drug effects , Cell Degranulation/drug effects , Cell Line , Chronic Urticaria/drug therapy , Mice , Phosphatidylinositol 3-Kinases/biosynthesis , Proto-Oncogene Proteins c-akt/biosynthesis , Rats , Wortmannin/pharmacology
7.
Int J Mol Sci ; 22(3)2021 Jan 30.
Article in English | MEDLINE | ID: mdl-33573189

ABSTRACT

Hyperglycemia alters the function of cerebral endothelial cells from the blood-brain barrier, increasing the risk of cerebrovascular complications during diabetes. This study evaluated the protective effect of polyphenols on inflammatory and permeability markers on bEnd3 cerebral endothelial cells exposed to high glucose concentration. Results show that hyperglycemic condition increased nuclear factor kappa B (NFκB) activity, deregulated the expression of interleukin-1 beta (IL-1ß), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), interleukin-10 (IL-10) and endothelial-leukocyte adhesion molecule (E-selectin) genes, raised MCP-1 secretion and elevated monocyte adhesion and transendothelial migration. High glucose decreased occludin, claudin-5, zona occludens-1 (ZO-1) and zona occludens-2 (ZO-2) tight junctions production and altered the endothelial permeability. Characterized polyphenolic extracts from the French medicinal plants Antirhea borbonica, Ayapana triplinervis, Dodonaea viscosa and Terminalia bentzoe, and their major polyphenols quercetin, caffeic, chlorogenic and gallic acids limited the pro-inflammatory and permeability alterations caused by high glucose. Peroxisome proliferator-activated receptor gamma (PPARγ) agonist also attenuated these damages while PPARγ antagonist aggravated them, suggesting PPARγ protective action. Interestingly, polyphenols improved PPARγ gene expression lowered by high glucose. Moreover, polyphenols were detected at the intracellular level or membrane-bound to cells, with evidence for breast cancer resistance protein (BCRP) efflux transporter role. Altogether, these findings emphasize the ability of polyphenols to protect cerebral endothelial cells in hyperglycemic condition and their relevance for pharmacological strategies aiming to limit cerebrovascular disorders in diabetes.


Subject(s)
Blood-Brain Barrier/drug effects , Cerebrovascular Disorders/prevention & control , Hyperglycemia/immunology , Plant Extracts/pharmacology , Polyphenols/pharmacology , ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism , Animals , Blood Glucose/metabolism , Blood-Brain Barrier/cytology , Blood-Brain Barrier/immunology , Blood-Brain Barrier/pathology , Capillary Permeability/drug effects , Capillary Permeability/immunology , Cell Line , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/immunology , Cerebrovascular Disorders/pathology , Drug Evaluation, Preclinical , Endothelial Cells/immunology , Endothelial Cells/pathology , Endothelium, Vascular/cytology , Endothelium, Vascular/immunology , Endothelium, Vascular/pathology , Humans , Hyperglycemia/blood , Hyperglycemia/complications , Mice , Monocytes/drug effects , Monocytes/immunology , NF-kappa B/metabolism , PPAR gamma/agonists , PPAR gamma/antagonists & inhibitors , PPAR gamma/metabolism , Plant Extracts/therapeutic use , Polyphenols/therapeutic use , Signal Transduction/drug effects , Tight Junctions/drug effects , Tight Junctions/immunology , Tight Junctions/pathology
8.
Yakugaku Zasshi ; 141(1): 41-45, 2021.
Article in Japanese | MEDLINE | ID: mdl-33390446

ABSTRACT

Diabetic retinopathy (DR) is a retinal disease representing one of the main causes of vision loss in developed countries. In the early stage of DR, disruption of blood retinal barrier (BRB) is observed, and it will lead to vascular permeability and visual impairment. Therefore, protection against the breakdown of BRB may be useful strategy for prevention of DR. Matrix metalloproteinases (MMPs) plays an important role in the degradation of extracellular matrix proteins. In DR, they attribute to increased vascular permeability by degrading the junction proteins, such as occuldin and cadherin that are important to maintain the BRB junction complex. Müller cells constitute the main glial cells of the retina and are involved in many retinal functions. They are reported to be one of the MMP-producing cells in the retina. In this symposium review, I present the molecular mechanism of MMP expression in retinal Müller cells. In addition, I would like to introduce polymethoxylated flavones, nobiletin and the derivatives isolated from natural resource as novel MMP inhibitors, which may be applicable to prevention of DR.


Subject(s)
Diabetic Retinopathy/etiology , Diabetic Retinopathy/prevention & control , Ependymoglial Cells/enzymology , Flavones/pharmacology , Matrix Metalloproteinase Inhibitors , Matrix Metalloproteinases/metabolism , Phytotherapy , Animals , Blood-Retinal Barrier/drug effects , Capillary Permeability/drug effects , Flavones/isolation & purification , Flavones/therapeutic use , Humans , Mice , Structure-Activity Relationship
9.
Toxins (Basel) ; 13(1)2021 Jan 08.
Article in English | MEDLINE | ID: mdl-33430137

ABSTRACT

Scyphozoan envenomation is featured as severe cutaneous damages due to the toxic effects of venom components released by the stinging nematocysts of a scyphozoan. However, the oedematogenic property and mechanism of scyphozoan venoms remain uninvestigated. Here, we present the oedematogenic properties of the nematocyst venom from Nemopilema nomurai (NnNV), a giant stinging scyphozoan in China, for the first time, using in vivo and in vitro models with class-specific inhibitors. NnNV was able to induce remarkable oedematogenic effects, including induction of significant oedema in the footpad and thigh of mouse, and increase in vascular permeability in the dorsal skin and kidney. Moreover, batimastat, a specific metalloproteinase inhibitor, could significantly reduce the Evan's blue leakage in the damaged organs and attenuate paw oedema after 12 h, but exerted no influence on NnNV-induced thigh oedema. These observations suggested a considerable contribution of NnNV metalloproteinase-like components to the increased vasopermeability, and the participation was strongly suggested to be mediated by destroying the integrity of the vascular basement membrane. Moreover, partial isolation combined LC-MS/MS profiling led to identification of the protein species Nn65 with remarkable metalloproteinase activity. This study contributes to the understanding of the effector components underlying the cutaneous damages induced by scyphozoan stings.


Subject(s)
Cnidarian Venoms/toxicity , Edema/chemically induced , Metalloproteases/toxicity , Scyphozoa/physiology , Administration, Topical , Animals , Capillary Permeability/drug effects , Carps , Chemical Fractionation , Chromatography, Gel , Injections, Intramuscular , Metalloproteases/metabolism , Mice , Mice, Inbred ICR
10.
Curr Drug Discov Technol ; 18(4): 525-531, 2021.
Article in English | MEDLINE | ID: mdl-32357814

ABSTRACT

INTRODUCTION: The present study deals with the effect of Nectaroscordum koelzi fruit extract on acute and chronic inflammation. METHODS: A total of 84 NMRI mice were used in this study. The effect of the extract on acute inflammation was analyzed by increasing vascular permeability via acetic acid and xylene induced ear edema among mice. The extract was evaluated in terms of effects on chronic inflammation by means of the cotton pellet test among mice. For the assessment of inflammation degree, the mice paw edema volume was measured by the plethysmometric test. RESULTS: The findings showed that the extract was effective on acute inflammation induced by acetic acid in mice. In the xylene ear edema, N. koelzi extract indicated a significant activity in mice. In the cotton pellet method, the methanol extract produced a significant reduction in comparison with the control and dexamethasone. Mice paw edema volume decreased with the extract. CONCLUSION: In general, the data from the experiments indicated that the methanol extract of N. koelzi has an anti-inflammatory effect on acute and chronic inflammation. However, the exact contributing mechanisms have not been investigated for the pharmacological effects.


Subject(s)
Allium/chemistry , Anti-Inflammatory Agents/pharmacology , Edema/drug therapy , Inflammation/drug therapy , Plant Extracts/pharmacology , Acetic Acid/administration & dosage , Acetic Acid/toxicity , Animals , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/therapeutic use , Capillary Permeability/drug effects , Capillary Permeability/immunology , Disease Models, Animal , Ear/blood supply , Edema/chemically induced , Edema/immunology , Edema/pathology , Humans , Inflammation/immunology , Male , Methanol/chemistry , Mice , Plant Extracts/isolation & purification , Plant Extracts/therapeutic use , Xylenes/administration & dosage , Xylenes/toxicity
11.
J Ethnopharmacol ; 267: 113490, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33091501

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Physalis Calyx seu Fructus is typically used to treat inflammatory diseases such as upper respiratory tract infection and acute tonsillitis in clinical practice of China. Physalin A, a main active ingredient of this traditional Chinese medicine (TCM), has been reported for its significant anti-tumor activity. However, most reports focused on the studies of its anti-tumor activity, the anti-inflammatory activity of physalin A and its molecular mechanism are still not elucidated clearly. AIM OF THE STUDY: The aim of the study was to investigate the anti-inflammatory activities both in vitro and in vivo and molecular mechanism of physalin A. MATERIALS AND METHODS: The potential anti-inflammatory properties of physalin A were evaluated in vitro by lipopolysaccharide (LPS)-induced RAW 264.7 macrophage cells, and in vivo via two typical acute inflammation murine models. Some important inflammation-related molecules were analyzed by enzyme-linked immuno sorbent assay (ELISA) and Western blotting. RESULTS: The results showed that physalin A inhibited carrageenan-induced paw edema of rats and capillary permeability of mice induced by acetic acid in vivo. Furthermore, physalin A also significantly reduced the release of inflammatory mediators nitric oxide (NO), prostaglandin E2 (PGE2), and tumor necrosis factor-α (TNF-α) induced by lipopolysaccharide (LPS) in RAW 264.7 in vitro. Further investigations indicated that physalin A can down-regulate the high expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in a dose-dependent manner. Physalin A remarkably blocked the degradation of inhibitor of nuclear factor kappa B alpha (IκB-α) and the nuclear translocation of nuclear factor-κB (NF-κB) p65 induced by LPS in RAW 264.7 cells. However, physalin A did not significantly inhibit the phosphorylation of mitogen-activated protein kinases (MAPKs) family proteins c-Jun N-terminal kinase (JNK) or extracellular signal-regulated kinase (ERK) or p38. CONCLUSIONS: All the results clearly illustrated that the anti-inflammatory action of physalin A is due to the inactivation of NF-κB signal pathway, but is irrelevant to the MAPKs pathway.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Edema/prevention & control , Inflammation Mediators/metabolism , Inflammation/prevention & control , Macrophages/drug effects , Withanolides/pharmacology , Acetic Acid , Animals , Capillary Permeability/drug effects , Carrageenan , Disease Models, Animal , Drug Synergism , Edema/chemically induced , Edema/metabolism , Edema/pathology , Inflammation/chemically induced , Inflammation/metabolism , Luteolin/pharmacology , Macrophages/metabolism , Male , Mice , NF-kappa B/metabolism , RAW 264.7 Cells , Rats, Sprague-Dawley , Signal Transduction
12.
J Ethnopharmacol ; 269: 113698, 2021 Apr 06.
Article in English | MEDLINE | ID: mdl-33338590

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Nymphaea hybrida Peck is used as a traditional medicinal herb for treating pain and inflammatory diseases, and known for its ornamental value and as a hot drink. However, the effects of N. hybrida polar fractions on lipopolysaccharide (LPS)-induced in vitro inflammation model and acute inflammation murine models have yet to be evaluated. AIM OF THE STUDY: The aim of this study was to elucidate the anti-inflammatory effects of N. hybrida ethanol extract (NHE) and its polar fractions: petroleum ether (PE), methylene chloride (MC), ethyl acetate (EA), methanol (ME), and water (WA). The underlying molecular mechanisms of active fraction in LPS-stimulated RAW 264.7 murine macrophages were further investigated. MATERIAL AND METHODS: Fractions with potential anti-inflammatory effects were screened using direct nitric oxide (NO) radical scavenging and cyclooxygenase (COX)-2 inhibition assays in vitro. The anti-inflammatory properties of potential fraction were evaluated in LPS-stimulated RAW264.7 cells, xylene-induced ear edema, carrageenan-induced paw edema and xylene-induced Evans blue exudation of acute inflammation murine models. The regulation of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways were investigated using western blotting and immunofluorescence. RESULTS: Compared to other polar fractions, NHE-EA displayed higher phenol and flavonoid content, and exerted greater activity in direct NO radical scavenging and COX-2 inhibition assay in vitro. NHE-EA markedly decreased the levels of inflammatory mediators, NO and prostaglandin E2 (PGE2), by suppressing the over-expression of inducible nitric oxide synthase (iNOS) and COX-2 in LPS-stimulated RAW264.7 cells. The NHE-EA fraction dose-dependently alleviated over-elevation of LPS-associated intracellular calcium and decreased the abnormal secretion of pro-inflammatory cytokines, tumor necrosis factor-α (TNF-α), interleukin-1ß (IL-1ß), IL-6, and interferon-γ (IFN-γ). The combination with NHE-EA effectively attenuated the activation and nuclear translocation of NF-κB p65, and the phosphorylation of extracellular signal-regulated kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 kinases of MAPK pathways. NHE-EA could significantly ameliorate the degree of swelling of the mice ear and paw, the skin exudation of Evans blue and the excessive secretion of inflammatory cytokines. CONCLUSION: Our results demonstrated that NHE-EA was the most active polar fraction of N. hybrida extracts. It inhibited the LPS-associated inflammatory response by blocking the activation of NF-κB and MAPKs pathways in RAW264.7 cells. It also effectively alleviated the inflammatory response of acute inflammation. These results indicated the role of NHE-EA as adjuvants and their potential role in alternative strategy for the treatment of inflammatory diseases.


Subject(s)
Acetates/chemistry , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Nymphaea/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Acute Disease , Animals , Anti-Inflammatory Agents/therapeutic use , Calcium/metabolism , Capillary Permeability/drug effects , Carrageenan/toxicity , Cell Survival/drug effects , Cyclooxygenase 2/drug effects , Cyclooxygenase 2/metabolism , Cytokines/metabolism , Dinoprostone/metabolism , Disease Models, Animal , Edema/chemically induced , Edema/drug therapy , Edema/pathology , Inflammation/metabolism , Lipopolysaccharides/toxicity , MAP Kinase Signaling System/drug effects , Male , Mice , Mice, Inbred ICR , NF-kappa B p50 Subunit/drug effects , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Otitis/chemically induced , Otitis/drug therapy , Otitis/pathology , Plant Extracts/chemistry , Plant Extracts/therapeutic use , RAW 264.7 Cells , Xylenes/toxicity
13.
Biosci Rep ; 40(10)2020 10 30.
Article in English | MEDLINE | ID: mdl-33030503

ABSTRACT

Bone morphogenetic protein-2 (BMP-2) is commonly applied in spinal surgery to augment spinal fusion. Nevertheless, its pro-inflammatory potential could induce dangerous side effects such as vascular hyper-permeability, posing the need for manners against this condition. The present study aims to investigate the protective effect of Zanthoxylum nitidum (ZN) on BMP-2-related hyperpermeability and inflammation on the human umbilical vein endothelial cells (HUVECs). The results revealed that, in a concentration-dependent manner, BMP-2 enhanced the production of pro-inflammatory cytokines, including interleukin (IL)-1α, IL-1ß, and tumor necrosis factor-α, which were, however, suppressed by ZN. ZN inhibited BMP-2-induced inflammatory response by suppressing the phosphorylation of NF-κBp65 and IκB, and the abnormal nuclear translocation of p65. Moreover, the inhibited expression intercellular tight junction protein VE-cadherin and Occludin caused by BMP-2 was blocked by ZN. The hyper-permeability of HUVECs induced by BMP-2, as expressed as the higher fluorescent intensity of dextran, was also reversed by ZN. Overall, these findings demonstrated that ZN antagonized BMP-2-induced inflammation and hyperpermeability. It could be a therapeutic candidate for the treatment of BMP-2-induced side effects during spinal fusion.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Bone Morphogenetic Protein 2/toxicity , Capillary Permeability/drug effects , Human Umbilical Vein Endothelial Cells/drug effects , Plant Extracts/pharmacology , Vasculitis/prevention & control , Zanthoxylum , Anti-Inflammatory Agents/isolation & purification , Cells, Cultured , Cytokines/metabolism , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/pathology , Humans , Inflammation Mediators/metabolism , NF-kappa B/metabolism , Phosphorylation , Plant Extracts/isolation & purification , Vasculitis/metabolism , Vasculitis/pathology , Zanthoxylum/chemistry
14.
Life Sci ; 261: 118460, 2020 Nov 15.
Article in English | MEDLINE | ID: mdl-32961234

ABSTRACT

AIMS: The hyperpermeability of gut-vascular barrier (GVB) plays a role in gut-derived sepsis. The goal of this study was to evaluate if berberine might improve hepatic apolipoprotein M (ApoM) generation and raise plasma ApoM level to protect the compromised GVB. MATERIALS AND METHODS: The compromised GVB was induced by sepsis. Hepatic ApoM mRNA and phosphoenolpyruvate carboxykinase (PEPCK) mRNA and plasma ApoM level were assayed by qRT-PCR and ELISA, respectively. The permeability of intestinal capillary in vivo and of rat intestinal microvascular endothelial cells (RIMECs) in vitro was assayed by FITC-dextran. The blood glucose was detected by a glucometer. Plasma insulin, TNF-α and IL-1ß were assayed by ELISA. The plasmalemma vesicle-associated protein-1 (PV1), ß-catenin and occludin in RIMECs were assayed by Western blot. KEY FINDINGS: Sepsis decreased hepatic ApoM mRNA and plasma ApoM level, but raised hepatic PEPCK mRNA and plasma glucose, insulin, TNF-α, and IL-1ß levels. The increased vascular endothelial permeability was abrogated by recombinant rat ApoM in vivo or ApoM-bound S1P in vitro. ApoM-bound S1P decreased PV1 but increased occludin and ß-catenin expression in LPS-treated RIMECs. Berberine in a dose-dependent manner raised hepatic ApoM mRNA and plasma ApoM level, but decreased septic hyperglycemia, insulin resistance and plasma TNF-α and IL-1ß levels. Berberine reduced sepsis-induced PEPCK and TLR4 mRNA overexpression in the liver. SIGNIFICANCE: This study demonstrated berberine inhibited TLR4-mediated hyperglycemia, insulin resistance and proinflammatory molecule production, thereby increasing ApoM gene expression and plasma ApoM. Berberine protected the damaged GVB via modulation of ApoM/S1P pathway.


Subject(s)
Apolipoproteins M/metabolism , Berberine/therapeutic use , Capillary Permeability/drug effects , Lysophospholipids/metabolism , Sepsis/drug therapy , Signal Transduction/drug effects , Sphingosine/analogs & derivatives , Animals , Berberine/pharmacology , Disease Models, Animal , Gastrointestinal Tract/blood supply , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/physiopathology , Hep G2 Cells , Humans , Male , Rats, Wistar , Sepsis/metabolism , Sepsis/physiopathology , Sphingosine/metabolism
15.
J Pharmacol Toxicol Methods ; 106: 106916, 2020.
Article in English | MEDLINE | ID: mdl-32890732

ABSTRACT

INTRODUCTION: The evaluation of microvascular permeability is crucial for drug development. Nonetheless, there are few reliable test methods in vitro due to the lack of vascular endothelial models suitable for quantitative analyses. The purpose of this study is to construct a novel microvascular endothelial model with the high endothelial barrier function and sensitivity to physiological stimuli utilizing a collagen vitrigel membrane (CVM) composed of high-density collagen fibrils. METHODS: Human microvascular endothelial cells (HMVECs) were cultured for 6 days in a CVM chamber with or without human dermal fibroblasts (HDFs) cocultured on the reverse surface of the CVM. The endothelial barrier function was evaluated by measurement of transendothelial electrical resistance (TEER) and macromolecular permeation. RESULTS: The TEER value of a monolayer of HMVECs cultured on the CVM was 15-20 Ωï½¥cm2 during the culture period while it reached over 60 Ωï½¥cm2 by coculturing with HDFs. The TEER value was decreased from 5.7 to 3.4 Ωï½¥cm2 by 100 µM histamine in the monolayer model and from 50 to 32 Ωï½¥cm2 by 1 nM histamine in the coculture model, respectively. Interestingly, the permeability coefficient of the compound with a molecular weight of not 376 and 40,000 but 4000 was selectively increased in the histamine-treated coculture model. DISCUSSION: HMVECs cocultured with HDFs via a CVM formed the tight endothelial barrier and showed high responsivity to histamine. The model might be useful for exploring molecules that modulate microvascular permeability and pass through the microvascular endothelial barrier.


Subject(s)
Capillary Permeability/drug effects , Endothelial Cells/drug effects , Endothelium, Vascular/drug effects , Histamine/pharmacology , Primary Cell Culture/methods , Cells, Cultured , Coculture Techniques , Collagen , Drug Evaluation, Preclinical/methods , Electric Impedance , Endothelial Cells/metabolism , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Feasibility Studies , Fibroblasts , Humans , Membranes, Artificial
16.
J Stroke Cerebrovasc Dis ; 29(9): 105071, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32807473

ABSTRACT

BACKGROUND: Chinese medicine Tongxinluo capsule (TXL) has been extensively used to treat ischemic stroke in China, and one of its mechanisms is to protect against blood brain barrier (BBB) disruption after stroke. However, the underlying protective mechanisms are not fully illuminated. It is reported that the low-density lipoprotein receptor-related protein 1 (LRP-1) is involved in BBB disruption after brain ischemia. In this study, we explored whether TXL could downregulate LRP-1 expression and subsequently protect against BBB disruption after stroke using permanent middle cerebral artery occlusion (pMCAO) in mice. METHODS: The animal model of ischemic stroke was induced by pMCAO in male adult C57BL/6J mice. The mice were orally administered TXL (3.0 g/kg) at 1, 3 and 21 h after pMCAO. Meanwhile, the LRP-1 antagonist receptor associated protein (RAP) was intracerebroventricularly injected at 1 and 21 h after stroke. We measured the following parameters at 6 and 24 h: LRP-1 protein level, BBB leakage, and the expression of tight junction (TJ) proteins including occludin, claudin-5 and zonula occludens-1 (ZO-1). RESULTS: Our results showed that TXL downregulated LRP-1 level, upregulated these TJ proteins level, and reduced BBB leakage in peri-infarct regions after pMCAO. Further study found that the inhibitor RAP played the same role as did TXL in upregulating these TJ proteins level and reducing BBB leakage after stroke. CONCLUSION: Our study demonstrates that TXL protects against BBB disruption after stroke via inhibiting the LRP-1 pathway.


Subject(s)
Blood-Brain Barrier/drug effects , Capillary Permeability/drug effects , Drugs, Chinese Herbal/administration & dosage , Infarction, Middle Cerebral Artery/drug therapy , Low Density Lipoprotein Receptor-Related Protein-1/metabolism , Administration, Oral , Animals , Blood-Brain Barrier/metabolism , Blood-Brain Barrier/pathology , Blood-Brain Barrier/physiopathology , Capsules , Disease Models, Animal , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/pathology , Infarction, Middle Cerebral Artery/physiopathology , Male , Mice, Inbred C57BL , Signal Transduction , Tight Junction Proteins/metabolism , Tight Junctions/drug effects , Tight Junctions/metabolism , Tight Junctions/pathology
17.
Microvasc Res ; 132: 104054, 2020 11.
Article in English | MEDLINE | ID: mdl-32768464

ABSTRACT

Ischemic stroke is a leading cause of mortality worldwide that occurs following the reduction or interruption of blood brain supply, characterized by a cascade of early events as oxidative stress and ensuing neuro-inflammation, energy failure and the burst of intracellular Ca++ resulting in activation of phospholipases and large increase in FFA including arachidonic acid, ultimately leading to nervous cell death. Grape Seed Flour (GSF) is a complex polyphenolic mixture harboring antioxidant, anti-inflammatory and neuroprotective properties. Orlistat (Xenical ™,Xe) is a gastro-intestinal lipase inhibitor and an anti-obesity agent. In an earlier study we reported the higher efficiency in neuroprotection against HFD-induced brain lipotoxicity when combining the two drugs (GSF + Xe). As a result repurposing Xe as an adjunct to GSF therapy against stroke appeared relevant and worthy of investigation. I/R insult disrupted the blood brain barrier (BBB) as assessed by EB dye extravasation, increased water and Na+ within the brain. Ultrastructurally I/R altered the brain blood capillaries at the vicinity of hippocampus dentate gyrus area as assessed by transmission and scanning electron microscopy. I/R altered lipid metabolism as revealed by LDL/HDL ratio, lipase activity, and FFA profiles. Moreover, I/R induced neuro-inflammation as assessed by down-regulation of anti-inflammatory CD 56 and up-regulation of pro-inflammatory CD 68 antigen. Importantly almost all I/R-induced disturbances were retrieved partially upon Xe or GSF on their own, and optimally when combining the two drugs. Xe per se is protective against I/R injury and the best neuroprotection was obtained when associating low dosage Xe with high dosage GSF, enabling neuroprevention and cell survival within hippocampus dentate gyrus area as revealed by increased staining of Ki 67 proliferation biomarker.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Blood-Brain Barrier/drug effects , Brain Edema/prevention & control , Capillary Permeability/drug effects , Grape Seed Extract/pharmacology , Lipid Metabolism/drug effects , Lipid Regulating Agents/pharmacology , Neuroprotective Agents/pharmacology , Orlistat/pharmacology , Reperfusion Injury/prevention & control , Stroke/prevention & control , Animals , Blood-Brain Barrier/metabolism , Blood-Brain Barrier/ultrastructure , Brain Edema/metabolism , Brain Edema/pathology , Disease Models, Animal , Inflammation Mediators/metabolism , Male , Rats, Wistar , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Stroke/metabolism , Stroke/pathology
18.
J Ethnopharmacol ; 261: 113143, 2020 Oct 28.
Article in English | MEDLINE | ID: mdl-32687958

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Solanum melongena L. (eggplant) is used for treatment of rheumatism, beriberi, itching, toothache, bleeding, asthma, bronchitis, cholera, neuralgia and hemorrhoids in traditional medicine (Turkish, Chinese, and Indian). Hemorrhoids from these diseases, are common illness in all over the world, which are treated with various approaches including ethnobotanicals. AIM OF THE STUDY: This study aimed to evaluate the anti-hemorrhoidal activity of eggplant, an edible plant, which is commonly utilized around the world. MATERIALS & METHODS: In vivo anti-hemorrhoidal activity of the methanolic extract prepared from eggplant was evaluated by experimental hemorrhoid model, subsequently histological and biochemical analysis. Hemorrhoid, which was induced by applying croton oil to the anal area of the rats. Furthermore, the extract was screened for anti-inflammatory activity which is based on the inhibition of acetic acid-induced increase in capillary permeability. The healing potential was comparatively assessed with a reference Pilex® tablet and cream. Phytochemical analysis performed by HPLC. The amount of the major phenolic compound (chlorogenic acid) in extract was found by using HPLC method. RESULTS: Histological and biochemical analysis demonstrated that eggplant extract is highly effective against hemorrhoid in comparison to the controls and the commercial preparation. In addition, the methanolic extract demonstrated significant inhibitory effect on acetic acid-induced increase in capillary permeability. The phytochemical studies identified major compound as chlorogenic acid (2.86%) by liquid chromatography. CONCLUSION: The eggplant calyxes, not edible, are easy to reach, by products/vast from the food sources. This is the first scientific evidence revealing that the eggplant extract has significant anti-hemorrhoidal and anti-inflammatory activity.


Subject(s)
Anal Canal/blood supply , Anti-Inflammatory Agents/pharmacology , Hemorrhoids/drug therapy , Plant Extracts/pharmacology , Solanum melongena , Wound Healing/drug effects , Animals , Anti-Inflammatory Agents/isolation & purification , Capillary Permeability/drug effects , Croton Oil , Disease Models, Animal , Hemorrhoids/chemically induced , Hemorrhoids/pathology , Male , Mice, Inbred BALB C , Plant Extracts/isolation & purification , Rats, Wistar , Solanum melongena/chemistry
19.
Am J Respir Cell Mol Biol ; 63(4): 519-530, 2020 10.
Article in English | MEDLINE | ID: mdl-32628869

ABSTRACT

KD025 is a ROCK2 inhibitor currently being tested in clinical trials for the treatment of fibrotic lung diseases. The therapeutic effects of KD025 are partly due to its inhibition of profibrotic pathways and fat metabolism. However, whether KD025 affects pulmonary microvascular endothelial cell (PMVEC) function is unknown, despite evidence that alveolar-capillary membrane disruption constitutes major causes of death in fibrotic lung diseases. We hypothesized that KD025 regulates PMVEC metabolism, pH, migration, and survival, a series of interrelated functional characteristics that determine pulmonary barrier integrity. We used PMVECs isolated from Sprague Dawley rats. KD025 dose-dependently decreased lactate production and glucose consumption. The inhibitory effect of KD025 was more potent compared with other metabolic modifiers, including 2-deoxy-glucose, extracellular acidosis, dichloroacetate, and remogliflozin. Interestingly, KD025 increased oxidative phosphorylation, whereas 2-deoxy-glucose did not. KD025 also decreased intracellular pH and induced a compensatory increase in anion exchanger 2. KD025 inhibited PMVEC migration, but fasudil (nonspecific ROCK inhibitor) did not. We tested endothelial permeability in vivo using Evans Blue dye in the bleomycin pulmonary fibrosis model. Baseline permeability was decreased in KD025-treated animals independent of bleomycin treatment. Under hypoxia, KD025 increased PMVEC necrosis as indicated by increased lactate dehydrogenase release and propidium iodide uptake and decreased ATP; it did not affect Annexin V binding. ROCK2 knockdown had no effect on PMVEC metabolism, pH, and migration, but it increased nonapoptotic caspase-3 activity. Together, we report that KD025 promotes oxidative phosphorylation; decreases glycolysis, intracellular pH, and migration; and strengthens pulmonary barrier integrity in a ROCK2-independent manner.


Subject(s)
Capillary Permeability/drug effects , Endothelial Cells/drug effects , Endothelium, Vascular/drug effects , Energy Metabolism/drug effects , Heterocyclic Compounds, 4 or More Rings/pharmacology , Lung/drug effects , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Adenosine Triphosphate/metabolism , Animals , Annexin A5/metabolism , Cell Movement/drug effects , Deoxyglucose/metabolism , Endothelial Cells/metabolism , Endothelium, Vascular/metabolism , Glycolysis/drug effects , Hydrogen-Ion Concentration , L-Lactate Dehydrogenase/metabolism , Lung/metabolism , Male , Oxidative Phosphorylation/drug effects , Propidium/pharmacology , Rats , Rats, Inbred F344 , Rats, Sprague-Dawley , Signal Transduction/drug effects , rho-Associated Kinases/metabolism
20.
Int J Biol Macromol ; 161: 1061-1069, 2020 Oct 15.
Article in English | MEDLINE | ID: mdl-32531369

ABSTRACT

Polysaccharide from marine alga Gracilaria caudata has potential health benefits, such as anti-inflammatory, gastroprotective and antidiarrheal effects. Here, we investigated the effect of a sulfated polysaccharide from G. caudata (SP-GC) on hypernociception and inflammatory response in arthritis models. The animals received SP-GC (3, 10 or 30 mg/kg) 1 h before tibio-tarsal injection of zymosan. Hypernociception, histopathology, edema, vascular permeability, myeloperoxidase (MPO) activity, cell influx, interleukin (IL)-1ß and nitric oxide (NO) levels were evaluated in acute phase. In another protocol, animals received SP-GC (30 mg/kg) 2 h post-complete Freund's adjuvant (CFA). Hypernociception, edema and arthritis index were determined in acute, sub-chronic and chronic phases. Rota-rod test measured the motor performance. SP-GC significantly reduced, in a dose-dependent manner, the zymosan-induced hypernociception with maximal effect at 30 mg/kg. The microscopic inflammation, joint edema, MPO activity, cell influx, IL-1ß and NO levels were also reduced by SP-GC. In the CFA-induced arthritis, SP-GC inhibits the hypernociception, edema and arthritic index in acute, sub-chronic and chronic phases. SP-GC did not alter the motor performance of animals. In conclusion, SP-GC exerts protective effect in models of arthritis due to the modulation of cell influx, IL-1ß and NO levels, culminating in the reduction of hypernociception and edema.


Subject(s)
Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Gracilaria/chemistry , Polysaccharides/chemistry , Polysaccharides/pharmacology , Sulfates/chemistry , Animals , Arthritis, Experimental/drug therapy , Arthritis, Experimental/etiology , Arthritis, Experimental/pathology , Biomarkers , Capillary Permeability/drug effects , Disease Models, Animal , Edema/drug therapy , Edema/etiology , Freund's Adjuvant , Immunohistochemistry , Male , Mice , Rodentia , Zymosan/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL